Prenatal exposure to benzodiazepines and the development of the offspring - a systematic review

Anne Grosbøl Jensen1, Signe Schöllhammer Knudsen2, Bodil Hammer Bech1

  • 1Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus, C, Denmark.

Insights

Prenatal exposure to benzodiazepines may increase risks for internalizing problems, impaired motor skills, and lower academic achievement in children. Further research is needed to confirm these findings and their clinical relevance.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Prenatal exposure to benzodiazepines is a concern due to potential long-term effects on child development.
  • Existing literature on the developmental outcomes of in utero benzodiazepine exposure requires systematic summarization.

Purpose of the Study:

  • To systematically review and synthesize available literature on the long-term developmental outcomes of children exposed to benzodiazepines during gestation.
  • To identify specific psychological, social, motor, and neurodevelopmental disturbances associated with prenatal benzodiazepine exposure.

Main Methods:

  • A systematic literature search was conducted across PubMed, PsycINFO, and Embase databases.
  • Included were 13 cohort studies of children over one year old with prenatal exposure to benzodiazepines or Z-hypnotics, comparing them to unexposed groups.
  • Internal validity of studies was assessed using the Newcastle Ottawa Scale (NOS).

Main Results:

  • Evidence suggests a potential increased risk of internalizing problems, impaired gross motor skills, lower academic achievement, and ADHD traits in children with prenatal benzodiazepine exposure.
  • Four developmental outcomes indicated impaired long-term development, though results were contradictory.
  • Potential bias and clinical relevance of findings remain uncertain.

Conclusions:

  • Prenatal benzodiazepine exposure is associated with several developmental outcomes, but findings are not definitive.
  • The study highlights a need for further high-quality research to clarify the long-term impact and clinical significance of in utero benzodiazepine exposure.
  • Uncertainty remains regarding the persistence of developmental issues into later childhood.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
418
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.4K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
538
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
558